These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21033070)

  • 81. Phalangeal fracture leading to digital amputation, sustained during manipulation for Dupuytren's disease as part of clostridial collagenase treatment.
    Richards K; Sethu C; Tiernan E
    Ann R Coll Surg Engl; 2019 Apr; 101(4):e102-e104. PubMed ID: 30855178
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The risk of skin tear in Dupuytren's disease when treated with collagenase.
    Fagernæs C; Mallet S
    Dan Med J; 2018 May; 65(5):. PubMed ID: 29726315
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Concerns for Collagenase.
    Slater RR
    J Hand Surg Am; 2016 Jun; 41(6):e157. PubMed ID: 27265765
    [No Abstract]   [Full Text] [Related]  

  • 84. Dupuytren Cords Do Not Undergo Significant Histopathological Change After Collagenase Clostridium Histolyticum Injection.
    Guo M; Yang K; Kock ND; Daley R; Dzwierzynski W; LoGiudice J; Hettinger P; Best C; Argenta A
    Hand (N Y); 2023 Sep; 18(6):912-917. PubMed ID: 35081825
    [No Abstract]   [Full Text] [Related]  

  • 85. Surgical findings in the treatment of Dupuytren's disease after initial treatment with clostridial collagenase (Xiaflex).
    Hay DC; Louie DL; Earp BE; Kaplan FT; Akelman E; Blazar PE
    J Hand Surg Eur Vol; 2014 Jun; 39(5):463-5. PubMed ID: 23649016
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Industry Sponsorship Bias in Collagenase Clinical Trials for Dupuytren Disease: A Meta-analysis.
    Gray KM; Khatiwada P; Capito AE
    Ann Plast Surg; 2024 Apr; 92(4):389-394. PubMed ID: 38527344
    [TBL] [Abstract][Full Text] [Related]  

  • 87. New drugs: Sipuleucel-T, cabazitaxel, and collagenase clostridium histolyticum.
    Hussar DA; Daniels WL
    J Am Pharm Assoc (2003); 2010; 50(6):772-5. PubMed ID: 21071329
    [No Abstract]   [Full Text] [Related]  

  • 88. Advances in Minimally Invasive Treatment of Dupuytren Disease.
    Hovius SER; Zhou C
    Hand Clin; 2018 Aug; 34(3):417-426. PubMed ID: 30012301
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Treatment of Recurrent Dupuytren Disease.
    Kaplan FTD; Crosby NE
    Hand Clin; 2018 Aug; 34(3):403-415. PubMed ID: 30012300
    [TBL] [Abstract][Full Text] [Related]  

  • 90. In Reply.
    Gaston RG
    J Hand Surg Am; 2016 Jun; 41(6):e157-8. PubMed ID: 27265764
    [No Abstract]   [Full Text] [Related]  

  • 91. Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.
    Warwick D; Arner M; Pajardi G; Reichert B; Szabo Z; Masmejean EH; Fores J; Chapman DS; Gerber RA; Huard F; Seghouani A; Szczypa PP;
    J Hand Surg Eur Vol; 2015 Feb; 40(2):124-32. PubMed ID: 24470559
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Effects of Collagenase Clostridium histolyticum on Plantar Fibromatosis: A Case Study.
    Lehrman JD; Miceli ALL; Tabchi SG; Kaplan MA
    J Foot Ankle Surg; 2019 Nov; 58(6):1281-1284. PubMed ID: 31679681
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Effect of Anticoagulation on the Treatment of Dupuytren Contracture with Collagenase.
    Paynter JA; Tobin V; Hurst LC; Badalamente MA; Hunter-Smith DJ; Rozen WM
    Plast Reconstr Surg; 2023 Apr; 151(4):693e. PubMed ID: 36729725
    [No Abstract]   [Full Text] [Related]  

  • 94. Collagenase for Dupuytren's disease of the thumb.
    Bendon CL; Giele HP
    J Bone Joint Surg Br; 2012 Oct; 94(10):1390-2. PubMed ID: 23015566
    [TBL] [Abstract][Full Text] [Related]  

  • 95. One year follow-up after treatment with CCH for Dupuytren's disease: A prospective view.
    Sanjuán-Cerveró R; Vazquez-Ferreiro P; Gómez-Herrero D; Carrera-Hueso FJ; Fikri-Banbrahim N
    Rev Esp Cir Ortop Traumatol (Engl Ed); 2018; 62(6):448-457. PubMed ID: 29519629
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Treatment of Recurrent Dupuytren Contracture in Joints Previously Effectively Treated With Collagenase Clostridium histolyticum.
    Bear BJ; Peimer CA; Kaplan FTD; Kaufman GJ; Tursi JP; Smith T
    J Hand Surg Am; 2017 May; 42(5):391.e1-391.e8. PubMed ID: 28341067
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Long-term clinical outcome of collagenase clostridium histolyticum treatment is independent of Dupuytren Diathesis Score.
    VAN Nuffel M; Posthuma DE Boer J; Cootjans K; Borgers A; DE Smet L; Degreef I
    Acta Orthop Belg; 2023 Jun; 89(2):233-240. PubMed ID: 37924539
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Pharmacotherapies in Dupuytren Disease: Current and Novel Strategies.
    Lambi AG; Popoff SN; Benhaim P; Barbe MF
    J Hand Surg Am; 2023 Aug; 48(8):810-821. PubMed ID: 36935324
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
    Watt AJ; Curtin CM; Hentz VR
    J Hand Surg Am; 2010 Apr; 35(4):534-9, 539.e1. PubMed ID: 20353858
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Analysis of efficacy and safety of treatment with collagenase Clostridium histolyticum among subgroups of patients with Dupuytren contracture.
    Raven RB; Kushner H; Nguyen D; Naam N; Curtin C
    Ann Plast Surg; 2014 Sep; 73(3):286-90. PubMed ID: 23511746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.